Article info
PDFClinical and epidemiological research
Concise report
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial
- Correspondence to Reiko Sato, Ph.D., Global Health Outcomes Assessment, Wyeth, 500 Arcola Road, E-Dock, Collegeville, PA 19426, USA; sator2{at}wyeth.com
Citation
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial
Publication history
- Accepted March 1, 2009
- First published March 16, 2009.
Online issue publication
December 09, 2009
Article Versions
- Previous version (16 March 2009).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.